Conversely, the study by Su et al. [31] focused on a patient with recurrent and metastatic radioactive iodine-refractory differentiated thyroid cancer harboring TERT promoter and BRAFV600E mutations. The gene discussed is TERT; the disease is differentiated thyroid carcinoma.